Common Contracts
2 similar Stock Purchase Agreement contracts by ProPhase Labs, Inc.
STOCK PURCHASE AGREEMENTStock Purchase Agreement • August 16th, 2021 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
THIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of August 10, 2021, is made by and among Nebula Genomics, Inc., a Delaware corporation (the “Company”), all of the shareholders of the Company, a list of which is contained on Schedule 4.3(a) (each a “Seller Party” and collectively, the “Seller Parties”), Kamal Obbad in the capacity as Seller Party Representative, ProPhase Labs, Inc., a Delaware corporation (“Parent”), and ProPhase Precision Medicine, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Buyer”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • October 26th, 2020 • ProPhase Labs, Inc. • Pharmaceutical preparations • Delaware
THIS STOCK PURCHASE AGREEMENT (this “Agreement”), dated as of October 22, 2020, is made by and among Confucius Plaza Medical Laboratory Corp., a New York corporation (the “Company”), Pride Diagnostics LLC (the “Selling Company”), Nelson Herrera, Arvind Gurnani and Michael Messina (together with the Selling Company, each a “Seller Party” and collectively, the “Seller Parties”), Arvind Gurnani, not individually but in the capacity as representative of the Seller Parties hereunder, and ProPhase Diagnostics, Inc., a Delaware corporation (“Buyer”).
